Evidence map›Paper›PMID 30787977›Full record

ArticleAmerican journal of translational research2019

Active surveillance for young patients with insular thyroid cancer: an initial and novel finding.

Zeming Liu, Wen Zeng, Ling Zhou, Wei Zhou, Danyang Chen, Haifeng Feng, Wei Wei, Chao Zhang, Min Wang, Liang Guo

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Zeming LiuDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Wen ZengDepartment of Ophthalmology, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Ling ZhouDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Wei ZhouDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Danyang ChenDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Haifeng FengDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Wei WeiDepartment of Pediatrics, St John Hospital and Medical Center Detroit 48236, MI, USA.
Chao ZhangDepartment of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430030, Hubei Province, China.
Min WangDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Liang GuoDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Wuhan University · CNSt. John Hospital & Medical Center · USWuhan Union Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insular thyroid cancer (ITC) is a relatively rare thyroid malignancy that has an unclear prognosis. Recent studies have indicated that watchful waiting is sufficient for younger patients with more differentiated thyroid lesions such as papillary thyroid microcarcinoma (PTMC). In this study, we investigated the prognosis of younger patients (< 45 and < 55 years old) with ITC and compared their outcomes to patients with PTMC and follicular thyroid microcarcinoma (FTMC). We hypothesized that ITC, like PTMC and FTMC, can be managed with active surveillance in younger patients with this disease. We investigated a large cohort of younger patients with ITC, PTMC, or FTMC who were listed in the Surveillance, Epidemiology, and End Results database between 2004 and 2013. Patient mortality was examined by Kaplan-Meier analyses with log-rank tests and Cox proportional hazards regression analyses. In the study cohort, the rate of cancer-specific mortality per 1000 person-years for younger ITC patients (< 45 and < 55 years) was lower than that for PTMC and FTMC. Kaplan-Meier analyses revealed that the cancer-specific and all-cause mortality rates in younger ITC patients were similar to those of PTMC and FTMC. Similar results were obtained when cases with tumor extension were excluded from the analysis. The unanticipated excellent prognosis of younger patients with ITC challenges the current clinical practice of automatically treating this disease, and offers new implications for management such as pursuing active surveillance instead.

Indexed as

Active surveillancecancer-specific survivalITCprognosisSEER

Identifiers

PMID30787977
PMCPMC6357322
OpenAlexW2980702539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.